- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Swedish Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
4
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
4 companies
Camurus
Market Cap: SEK 41.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 702.00
7D
2.2%
1Y
8.0%
Bonesupport Holding
Market Cap: SEK 21.4b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 324.40
7D
9.4%
1Y
9.7%
BioGaia
Market Cap: SEK 10.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.30
7D
-5.6%
1Y
-19.0%
Genovis AB (publ.)
Market Cap: SEK 1.8b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 27.85
7D
0.2%
1Y
-2.1%